Renaissance Technologies »

Co-Diagnostics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Co-Diagnostics (CODX) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Co-Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Co-Diagnostics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Co-Diagnostics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-06-30 $39k 13k 3.10

More positions owned by Renaissance Technologies

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Intel Corporation (INTC)
United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl A (GOOGL)
Exelixis (EXEL)
Verisign (VRSN)
Kinross Gold Corp (KGC)
Crowdstrike Hldgs Cl A (CRWD)
Sterling Construction Company (STRL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Argan (AGX)
Netflix (NFLX)

View all positions for Renaissance Technologies

Top funds holding Co-Diagnostics

Armistice Capital
Jane Street
Vanguard Capital Management
Private Advisory
Millennium Management
Susquehanna International
Geode Capital Management
Vanguard Fiduciary Trust
Virtu Financial
UBS Group
Renaissance Technologies
Smartleaf Asset Management
Global Retirement Partners
Morgan Stanley
SBI Securities

View all funds holding Co-Diagnostics